Ning Liao, MD, PhD

The Director, Department of Breast Cancer, Cancer Center, Guangdong General Hospital, Guangzhou, China

Title and Membership
Member of expert group of <Guideline for Treatment of Breast Cancer>, Ministry of Health, PRC
Member of expert group of <Guideline for Diagnosis of Breast Cancer>, Ministry of Health, PRC
Member of expert group of Rational drug use committee, Ministry of Health, PRC

International Visiting Scholarship
1997-1999, Visiting Scholar, French National Cancer Center
2006,Visiting Scholar in Breast Cancer Medical Oncology, Odense University Medical School, Denmark
2013,Visiting Scholar, European Institute for Cancer Research, Milan, Italy
2014,Visiting Scholar, MD Anderson Cancer Center, USA

Awards
Gold Metal of 2011 Round Asia Oncology Forum (RAOF) ,<GSTM1 mRNA expression polymorphism correlates with responsive neoadjuvant chemotherapy in Chinese ER positive patients>
Silver and Bronze Metal of 2010 Round Asia Oncology Forum (RAOF), <21-gene recurrence score based on fresh frozen core needle biopsy tumor tissues predicts response to neoadjuvant chemotherapy in Chinese ER positive breast cancer patients>, < HER2 positivity correlates to coexisting invasion in ductal carcinoma in situ of the breast>

Expertise in clinical practice
Dr. Liao has been practicing clinical breast oncology and is an expert in early diagnosis and multi-disciplinary comprehensive treatment for breast cancer (including minimally invasive breast surgery, individualized chemotherapy and endocrine therapy). Benefiting from visiting scholarship in multiple world renowned cancer centers, Dr. Liao has been the leading expert in the field of minimally invasive breast surgery in China. Meanwhile, Dr. Liao is among surgeons who carried out oncoplastic breast conserving surgery in the first place. 

Excellence in scientific research
Dr. Liao was sponsored by NSFC youth research program(2011) and is the principle investigator (PI) of a Chinese National Science Foundation Committee research program. Dr. Liao has also directed multiple key research programs in Guangdong Science Foundation Committee. She is the editor in chief of “Molecular Basis of Breast Cancer”(Chinese edition, author: Jose Russo and Irma H. Russo) and has published some articles in SCI enlisted journals and key Chinese scientific journals.